Parker Charles Nolan has filed 4 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 15393 shares of Traws Pharma, Inc. ($TRAW) on December 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Parker Charles Nolan | Chief Financial Officer | A | Common Stock | 15393 | $0.00 | 15,393.0000 | 8,818,859 | 9999.99% | 0.17% |
| Oct. 12, 2025 | Traws Pharma, Inc. | $TRAW | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 61571 | $0.00 | 61,571.0000 | 8,818,859 | 9999.99% | 0.70% |
| March 8, 2026 | Traws Pharma, Inc. | $TRAW | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 104544 | $0.00 | 104,544.0000 | 8,818,859 | 9999.99% | 1.19% |